Comprehensive technology-assisted training and supervision program to enhance depression management in primary care in Santiago, Chile: study protocol for a cluster randomized controlled trial

Trials. 2015 Jul 24:16:311. doi: 10.1186/s13063-015-0845-4.

Abstract

Background: Depression is a common and disabling condition. Since 2001, Chile has had a national program for depression in primary care and universal access to treatment for depressed people over the age of 15. There are National Guidelines to treat depression but no training program exists. The aim of the present study protocol is to measure the effectiveness of a comprehensive technology-assisted training and supervision program to enhance depression management in primary care.

Methods and design: This is a two-arm, single-blind, cluster randomized controlled trial to compare the efficacy of the program versus usual care to treat depression in primary care clinics. In total, 434 depressed persons 18 to 65 years of age, recruited from four primary care clinics located in Santiago, will participate in the study.

Discussion: In order to ensure the quality of interventions supported by the national program for depression in Chile, it is desirable to have training programs of proven effectiveness.

Trial registration: NCT02232854, registered on 2 September 2014.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Chile
  • Depression / diagnosis
  • Depression / psychology
  • Depression / therapy*
  • Education, Medical, Continuing*
  • Education, Nursing, Continuing
  • Female
  • Humans
  • Inservice Training*
  • Male
  • Middle Aged
  • National Health Programs
  • Patient Care Team
  • Patient Compliance
  • Primary Health Care*
  • Psychiatric Status Rating Scales
  • Quality of Life
  • Remission Induction
  • Research Design
  • Single-Blind Method
  • Surveys and Questionnaires
  • Time Factors
  • Treatment Outcome
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT02232854